Castle Biosciences

$71.87
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$3.30 (+4.81%) As of 4:27 PM UTC today

Why Robinhood?

You can buy or sell CSTL and other stocks, options, and ETFs commission-free!

About CSTL

Castle Biosciences, Inc. Common Stock, also called Castle Biosciences, is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients.

CEO
Derek J. Maetzold
Employees
201
Headquarters
Friendswood, Texas
Founded
2007
Market Cap
1.88B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
320.49K
High Today
$71.89
Low Today
$68.69
Open Price
$68.69
Volume
79.81K
52 Week High
$107.69
52 Week Low
$26.13

CSTL Earnings

-$0.40
-$0.23
-$0.06
$0.11
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, After Hours

You May Also Like

VYNT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure